African Swine Fever Virus pI10L Enhances Antiviral Immune Responses by Promoting MAVS-TRAF6 Signaling

Viruses are relentless invaders, and the first line of defense in any animal body is the innate immune system. This is an immediate, automatic alarm system that detects intruders and sounds the call to arms before the body can mount a more specific, long-term attack. When a virus enters a cell, the cell's sensors recognize the foreign genetic material and trigger a cascade of signals. These signals travel to the cell's command center, instructing it to release interferons—powerful chemical messengers that warn neighboring cells to tighten their defenses and activate genes that fight the infection. For many years, scientists have known that the African swine fever virus, a deadly pathogen affecting pigs worldwide, is a master at disarming this alarm system. It produces a suite of proteins designed to shut down these immune signals, allowing the virus to replicate unchecked. This evasion is a primary reason why no effective vaccine exists yet; understanding exactly how the virus tricks the host is essential for finding a way to stop it.

In a recent study, researchers at Nanjing Agricultural University and the China Animal Health and Epidemiology Center uncovered a surprising twist in this biological battle. They focused on a specific protein produced by the African swine fever virus called pI10L. For a long time, scientists believed this protein acted solely as a saboteur, helping the virus hide from the immune system. However, the new findings reveal that pI10L actually does the opposite in one critical context: it boosts the very immune response it was thought to suppress. The researchers discovered that this viral protein interacts directly with a key cellular protein called MAVS, which acts as a central hub for antiviral signaling. Instead of breaking this hub, pI10L helps it assemble into larger, more active clusters. By doing so, it recruits another important protein, TRAF6, which stabilizes the signal and ensures a strong production of interferons and other immune factors.

The team tested this by introducing the pI10L gene into pig cells and then stimulating the cells with a synthetic molecule that mimics viral RNA. They observed that the presence of pI10L significantly increased the production of interferon-beta and other antiviral genes compared to cells without the protein. To understand the mechanism, they looked closely at how pI10L binds to the cellular machinery. They found that pI10L latches onto the mitochondrial antiviral signaling protein, MAVS, specifically at a region near the cell's outer membrane. This binding encourages MAVS to clump together into large aggregates, a necessary step for activating the immune response. Furthermore, pI10L grabs onto TRAF6, a protein that helps transmit the signal further down the line. The researchers found that pI10L protects TRAF6 from being broken down by the cell's natural recycling machinery, effectively increasing the amount of TRAF6 available to fight the virus.

This dual action—helping MAVS clump together and keeping TRAF6 stable—results in a much stronger immune signal. When the researchers reduced the amount of pI10L in cells infected with the actual African swine fever virus, the immune response weakened, and the virus replicated more rapidly. Conversely, when they added extra pI10L to the infected cells, the immune response surged, and viral replication slowed down. These results suggest that, contrary to the behavior of many other viral proteins that act as pure suppressors, pI10L functions as a positive regulator of the innate immune system in this specific pathway. It appears the virus may use this protein to fine-tune the host's immune response, perhaps to avoid triggering a reaction that is too strong and immediately lethal, or to manipulate the timing of the infection in a way that benefits its own spread.

The study also clarified how pI10L fits into the broader picture of viral immune evasion. While previous research showed that pI10L can inhibit certain inflammatory pathways triggered by other signals, this work demonstrates that it actively promotes the antiviral pathway driven by MAVS and TRAF6. The researchers confirmed that the protein does not interfere with the ubiquitination process that usually activates MAVS, but rather facilitates the physical aggregation of the protein. They also showed that pI10L prevents a specific type of chemical tagging on TRAF6 that would normally mark it for destruction. By stopping this degradation, the virus protein inadvertently strengthens the cell's ability to produce interferons.

These findings offer a new perspective on the complex relationship between African swine fever virus and its host. Rather than a simple story of a virus suppressing all immune activity, the reality appears to be a nuanced interaction where the virus manipulates specific parts of the immune system to its advantage. The discovery that pI10L enhances the MAVS-TRAF6 signaling pathway challenges the assumption that all viral immune evasion proteins are purely inhibitory. It suggests that the virus may rely on this protein to modulate the host response, creating a balance that allows the infection to persist without triggering an immediate, overwhelming defense. For scientists working toward a vaccine, this insight is crucial. It highlights that understanding the full range of viral protein functions, including those that might seem counterintuitive, is necessary to design strategies that can effectively outmaneuver the virus and protect pig populations from this devastating disease.